Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

Summary

The purpose of this clinical trial is to demonstrate the superiority of fusidic acid 1% over placebo in adults and children with confirmed bacterial conjunctivitis and to further establish the safety profile of fusidic acid 1% for topical ocular administration.

Timeline

Start

2025-03-21

Primary completion

2026-03-16

Completion

2026-03-23

Drugs

Indications